PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7233442-0	1981	Depression of cytochrome P-450-dependent drug biotransformation by adriamycin.	Doxorubicin	67-77	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	14-30	
27452206-3	2016	Dimerization is required for association with cytochrome P450 (cyP450) enzymes, which mediates chemoresistance to doxorubicin and may be responsible for PGRMC1"s anti-apoptotic activity.	Doxorubicin	114-125	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	46-61	
27452206-3	2016	Dimerization is required for association with cytochrome P450 (cyP450) enzymes, which mediates chemoresistance to doxorubicin and may be responsible for PGRMC1"s anti-apoptotic activity.	Doxorubicin	114-125	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	63-69	
2250572-1	1990	The administration of doxorubicin, an anti-tumor antibiotic, to rodents resulted in an increase in heme oxygenase activity and a decrease in delta-aminolevulinate (ALA) synthase activity and in cellular heme and cytochrome P450 content in liver.	Doxorubicin	22-33	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	212-227	
2250572-3	1990	Sn-protoporphyrin thus provides a pharmacological means of protecting against the toxic effects of doxorubicin and other drugs which enhance heme oxygenase activity and thus decrease cellular heme and cytochrome P450 content in vivo.	Doxorubicin	99-110	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	201-216